Cooley advised RAPT Therapeutics, while Davis Polk advised the joint book-running managers in the offering.RAPT Therapeutics, Inc. executed a $75 million SEC-registered follow-on offering of 4,054,055 shares…
This content is for Standard 1 Year members only. LoginJoin Now
Author: Laura Testa
…
This content is for Standard 1 Year members only. LoginJoin Now